Search
Search Results
##search.searchResults.foundPlural##
-
Glucocorticoids and antivirals for HBV reactivation in onco-hematologic patients
1044PDF: 599HTML: 2227Cover Letter: 228 -
LYMPHOCYTES IN PATIENTS WITH CHRONIC ACTIVE EPSTEIN-BARR VIRUS INFECTION EXHIBITED ELEVATED PD-1/PD-L1 EXPRESSION AND A PREVAILING TH2 IMMUNE RESPONSE. EPSTEIN-BARR VIRUS INFECTION EXHIBITED ELEVATED PD-1/PD-L1
3037PDF: 1157HTML: 133 -
HHVs AND LYMPHOPROLIFERATIVE DISORDERS
1497PDF: 872HTML: 3143 -
INFECTIONS AND FOLLICULAR LYMPHOMA: IS THERE A LINK?
3380PDF: 1095HTML: 2425 -
THE IMPACT OF HUMAN PLATELET ANTIGEN ALLELE ON ANTIPLATELET ANTIBODIES AND CRYOGLOBULINS IN PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA AND HEPATITIS C VIRUS-ASSOCIATED IMMUNE THROMBOCYTOPENIA Human platelet antigen and immune thrombocytopenia
1218PDF: 1041Suppl. Files: 489HTML: 363 -
MALARIA AND HIV IN ADULTS: When The Parasite runs into The Virus
2804PDF: 1076HTML: 2394 -
Lymphomatoid Granulomatosis of Central Nervous System and Lung Driven by Epstein Barr Virus Proliferation: Successful Treatment with Rituximab
1718PDF: 960HTML: 3196Figure 5: 189Figure 4: 187Figure 3: 224Figure 1: 202Figure 2: 202 -
HIV-ASSOCIATED VENOUS THROMBOEMBOLISM
4614PDF: 1546HTML: 8545 -
DEMOGRAPHICAL, VIRO-IMMUNOLOGICAL, CLINICAL AND THERAPEUTICAL CHARACTERISTICS OF HIV INFECTED PATIENTS IN A “EPIDEMIOLOGICALLY UNEXPLORED” REGION OF ITALY (CALABRIA REGION): THE CALABRHIV COHORT.
1722PDF: 870HTML: 1279Figure 1: 208Figure 2: 220Figure 3: 221 -
NOVEL MUTATIONS IN THE NON-STRUCTURE PROTEIN 2 OF SARS-CoV-2 Sequence analysis NSP2 of SARS-CoV-2
1101PDF: 520HTML: 161 -
Epstein-Barr Virus (EBV)-associated Haemophagocytic Syndrome
1940PDF: 895HTML: 1644 -
Editorial : INTRODUCING MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES
3446PDF: 623HTML: 730 -
COMPARISON OF INFECTIOUS COMPLICATIONS IN PATIENTS RECEIVING HIGH-DOSE CYCLOPHOSPHAMIDE AS GVHD AFTER TRANSPLANTATION FROM A 9/10 HLA-MATCHED UNRELATED DONOR WITH STANDARD GVHD PROPHYLAXIS AFTER TRANSPLANT FROM A FULL MATCHING DONOR Infection With PTCy Versus Standard GvHD Prophylaxis
1546PDF: 1384HTML: 120 -
Acute Cytomegalovirus infection as a cause of venous thromboembolism
1657PDF: 891HTML: 1083Picture 1: 201 -
Cardiac toxicity associated with HCV direct antiviral agents Heart in HCV DAAs therapy
1685PDF: 1027HTML: 232 -
HIV INFECTION, ANTIRETROVIRAL THERAPY AND CARDIOVASCULAR RISK
1953PDF: 839HTML: 3691 -
Refractory Immune Thrombocytopenic Purpura and Cytomegalovirus Infection: A Call for a Change in the Current Guidelines
4450PDF: 1256HTML: 2419Figure 1: 212 -
MEDICAL TREATMENT OF HEPATOCELLULAR CARCINOMA
775PDF: 489HTML: 6286 -
A HEALTH RELATED QUALITY OF LIFE AND PSYCHOPATHOLOGICAL SYMPTOMS IN PEOPLE WITH HEMOPHILIA, BLOODBORNE CO-INFECTIONS AND COMORBIDITIES: AN ITALIAN MULTICENTER OBSERVATIONAL STUDY PSYCHOLOGICAL DINAMICS OF A GROUP OF ITALIAN HEMOPHILIACS WITH AND WITHOUT (CO)INFECTIONS AND COMORBIDITIES: A MULTICENTER STUDY
1647PDF: 1297HTML: 535 -
PATHOGENESIS OF MALARIA IN TISSUES AND BLOOD
4721PDF: 2016HTML: 18177 -
CLINICAL ASPECTS OF UNCOMPLICATED AND SEVERE MALARIA
8313PDF: 4487HTML: 7575 -
Seroprevalence of transfusion-transmissible infections among family replacement donors and voluntary non-remunerated blood donors during the COVID-19 pandemic in sub Saharan Africa family replacement donors and voluntary non-remunerated blood donors in transfusion transmissible infections
1719PDF: 1366HTML: 176 -
Status Epilepticus Due to Severe HHV-6 Encephalitis in an Allogeneic Stem Cell Transplant Recipient
1247PDF: 880HTML: 2196Figue 1: 203







